1. Home
  2. IMCR vs HELE Comparison

IMCR vs HELE Comparison

Compare IMCR & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCR
  • HELE
  • Stock Information
  • Founded
  • IMCR 2008
  • HELE 1968
  • Country
  • IMCR United Kingdom
  • HELE United States
  • Employees
  • IMCR N/A
  • HELE N/A
  • Industry
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • HELE Home Furnishings
  • Sector
  • IMCR Health Care
  • HELE Consumer Discretionary
  • Exchange
  • IMCR Nasdaq
  • HELE Nasdaq
  • Market Cap
  • IMCR 1.4B
  • HELE 1.3B
  • IPO Year
  • IMCR 2021
  • HELE N/A
  • Fundamental
  • Price
  • IMCR $30.16
  • HELE $28.61
  • Analyst Decision
  • IMCR Buy
  • HELE Buy
  • Analyst Count
  • IMCR 12
  • HELE 3
  • Target Price
  • IMCR $60.90
  • HELE $56.33
  • AVG Volume (30 Days)
  • IMCR 378.9K
  • HELE 811.4K
  • Earning Date
  • IMCR 05-07-2025
  • HELE 04-24-2025
  • Dividend Yield
  • IMCR N/A
  • HELE N/A
  • EPS Growth
  • IMCR N/A
  • HELE N/A
  • EPS
  • IMCR N/A
  • HELE 5.37
  • Revenue
  • IMCR $310,202,000.00
  • HELE $1,907,665,000.00
  • Revenue This Year
  • IMCR $20.52
  • HELE $7.57
  • Revenue Next Year
  • IMCR $8.57
  • HELE $2.29
  • P/E Ratio
  • IMCR N/A
  • HELE $5.33
  • Revenue Growth
  • IMCR 24.36
  • HELE N/A
  • 52 Week Low
  • IMCR $23.15
  • HELE $27.76
  • 52 Week High
  • IMCR $62.74
  • HELE $110.76
  • Technical
  • Relative Strength Index (RSI)
  • IMCR 59.11
  • HELE 24.96
  • Support Level
  • IMCR $27.55
  • HELE $30.60
  • Resistance Level
  • IMCR $30.85
  • HELE $36.58
  • Average True Range (ATR)
  • IMCR 1.95
  • HELE 3.40
  • MACD
  • IMCR 0.44
  • HELE -0.40
  • Stochastic Oscillator
  • IMCR 89.02
  • HELE 4.85

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: